Dr. Amish Shah

Carol Shields is an Oncologist and an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is currently accepting new patients.

Sarah Easaw is an Oncologist and a Hematologist in Lakewood, New Jersey. Dr. Easaw is rated as a Distinguished provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Myelodysplastic Syndrome (MDS), RUNX1 Familial Platelet Disorder, Paget Disease of the Breast, and Breast Cancer. Dr. Easaw is currently accepting new patients.

Philosophy of care | Personalized care starts during my first meeting with a patient and family. That's when I get to know the patient as completely as possible. I want to know about the patient's concerns, values and support system so I can provide care that is specific to him or her. | Also, I am a member of the skin and soft tissue cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | When I was young, I didn't like seeing doctors. It created a lot of anxiety for me. Now that I'm older, I can relate to the way people feel, especially when they're coping with the emotions caused by a serious condition like cancer. My grandmother died of uterine cancer in the 1960s. During her battle, I felt helpless. That is what attracted me to cancer research. Now I see the amazing progress we are making through cancer research. | Community involvement | I served on the state board of the American Cancer Society. Today, I take more of a grassroots approach to offer my support. I participate in events, such as 5K runs, that benefit charities. Dr. Nair is rated as a Distinguished provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Adult Soft Tissue Sarcoma, and Melanoma.